EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-5.95%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.24B
AUM Growth
-$312M
(-5.6%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
19.63%
Holding
944
New
50
Increased
219
Reduced
167
Closed
31
Top Buys
| 1 |
Pfizer
PFE
|
$26.7M |
| 2 |
Sunrun
RUN
|
$20.2M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
$19.3M |
| 4 |
Danaher
DHR
|
$14.7M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
$13.5M |
Top Sells
| 1 |
Foot Locker
FL
|
$42.5M |
| 2 |
Walmart
WMT
|
$16M |
| 3 |
Masimo
MASI
|
$15.8M |
| 4 |
Enovis
ENOV
|
$14.8M |
| 5 |
JPMorgan Chase
JPM
|
$14.1M |
Sector Composition
| 1 | Technology | 31.7% |
| 2 | Healthcare | 18.75% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Financials | 9.73% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Air Products & Chemicals
APD
$64.5B
| $1.43M | 0.03% |
5,650
-1,170
| -17% | -$296K |
|
327
Enbridge
ENB
$105B
| $1.42M | 0.03% |
30,700
-3,000
| -9% | -$139K |
|
|
ITCI
328
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.41M | 0.03% |
23,400
+2,400
| +11% | +$145K |
|
329
Goldman Sachs
GS
$223B
| $1.4M | 0.03% |
4,161
+1,563
| +60% | +$525K |
|
330
Medpace
MEDP
$13.7B
| $1.38M | 0.03% |
8,450
| – | – |
|
331
Netflix
NFLX
$529B
| $1.37M | 0.03% |
3,573
-15,899
| -82% | -$6.12M |
|
332
Paychex
PAYX
$48.7B
| $1.37M | 0.03% |
10,000
-30,800
| -75% | -$4.22M |
|
|
B
333
Barrick Mining Corporation
B
$48.5B
| $1.31M | 0.03% |
53,600
| – | – |
|
334
Cadence Design Systems
CDNS
$95.6B
| $1.31M | 0.02% |
8,000
| – | – |
|
335
Aflac
AFL
$57.2B
| $1.29M | 0.02% |
19,700
| – | – |
|
336
Ascendis Pharma
ASND
$12.5B
| $1.29M | 0.02% |
11,100
-2,900
| -21% | -$336K |
|
337
Arvinas
ARVN
$575M
| $1.28M | 0.02% |
20,000
-2,700
| -12% | -$172K |
|
338
DexCom
DXCM
$31.6B
| $1.23M | 0.02% |
9,452
+2,960
| +46% | +$384K |
|
339
GeoPark
GPRK
$326M
| $1.2M | 0.02% |
80,000
| – | – |
|
340
Mondelez International
MDLZ
$79.9B
| $1.18M | 0.02% |
18,851
+4,866
| +35% | +$305K |
|
341
Intellia Therapeutics
NTLA
$1.29B
| $1.18M | 0.02% |
16,345
+6,500
| +66% | +$469K |
|
|
SPLK
342
DELISTED
Splunk Inc
SPLK
| $1.14M | 0.02% |
8,000
| – | – |
|
343
Amicus Therapeutics
FOLD
$2.46B
| $1.12M | 0.02% |
116,850
-15,150
| -11% | -$146K |
|
344
Insmed
INSM
$30.7B
| $1.09M | 0.02% |
47,600
| – | – |
|
345
ServiceNow
NOW
$190B
| $1.08M | 0.02% |
1,881
-6,144
| -77% | -$3.53M |
|
346
Verisk Analytics
VRSK
$37.8B
| $1.08M | 0.02% |
5,000
| – | – |
|
347
Ultragenyx Pharmaceutical
RARE
$3.07B
| $1.07M | 0.02% |
15,010
-2,200
| -13% | -$157K |
|
348
STAAR Surgical
STAA
$1.38B
| $1.06M | 0.02% |
12,803
+3,300
| +35% | +$273K |
|
349
Xenon Pharmaceuticals
XENE
$3.02B
| $1.05M | 0.02% |
35,000
| – | – |
|
350
iShares MSCI ACWI ETF
ACWI
$22.1B
| $1.03M | 0.02% |
10,360
+1,065
| +11% | +$106K |
|